Feasibility of dasatinib in children and adolescents with new or recurrent central nervous system germinoma
Authors:
- 10 June 2013
- journal article
- clinical trial
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 60 (9) , E100-E102
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registriesNeuro-Oncology, 2012
- Longitudinal evaluation of neurocognitive function after treatment for central nervous system germ cell tumors in childhoodCancer, 2011
- Primary chemotherapy for intracranial germ cell tumors: Results of the third international CNS germ cell tumor studyPediatric Blood & Cancer, 2010
- Pediatric Central Nervous System Germ Cell Tumors: A ReviewThe Oncologist, 2008
- c‐kit gene mutations in intracranial germinomasCancer Science, 2004
- Primary Chemotherapy for Intracranial Nongerminomatous Germ Cell Tumors: Results of the Second International CNS Germ Cell Study Group ProtocolJournal of Clinical Oncology, 2004
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumorsJournal of Neurosurgery, 2002
- Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: From the First International CNS Germ-Cell Tumor StudyNeuro-Oncology, 2001
- Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.Journal of Clinical Oncology, 1996